PSMA I&T, CAS 2192281-54-0

Product Description: PSMA I&T is an effective inhibitor of prostate-specific membrane antigen (PSMA). PSMA I&T can be used for SPECT/CT imaging and radionuclide studies in triple-negative breast cancer and prostate cancer (PCa)[1][2].

Applications: Cancer-programmed cell death

Formula: C63H92IN11O23

References: [1]Chatalic KL, et al. Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent. Theranostics. 2016 Apr 12;6(6):849-61./[2]Amelie Heesch, et al. The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177Lu]Lu-PSMA-I&T for triple-negative breast cancer. Breast Cancer Res. 2024 Feb 20;26(1):30.

CAS Number: 2192281-54-0

Molecular Weight: 1498.37

Compound Purity: 99.67

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic;warming;heat to 60°C)/H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)

Target: PSMA

• SKU: MEXHY-148761-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-148761-10
• Package Unit: 10 mg
• Quantity Unit: STK